イレウス(腸閉塞) (Ileus (Intestinal Obstruction)):世界の治験レビュー(2015年上半期版)

◆英語タイトル:Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2679CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年4月30日
◆ページ数:80
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥840,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、世界におけるイレウス(腸閉塞) (Ileus (Intestinal Obstruction)) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - イレウス(腸閉塞) (Ileus (Intestinal Obstruction))
  - 当レポートの概要
・イレウス(腸閉塞) (Ileus (Intestinal Obstruction)):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015″ provides data on the Ileus (Intestinal Obstruction) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ileus (Intestinal Obstruction) . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ileus (Intestinal Obstruction) . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Ileus (Intestinal Obstruction) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Ileus (Intestinal Obstruction) 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Ileus (Intestinal Obstruction) Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Tsumura & co. 31
Clinical Trial Overview of Tsumura & co. 31
Valeant Pharmaceuticals International, Inc. 33
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 33
Merck & Co., Inc. 34
Clinical Trial Overview of Merck & Co., Inc. 34
Norgine B.V. 35
Clinical Trial Overview of Norgine B.V. 35
Ipsen S.A. 36
Clinical Trial Overview of Ipsen S.A. 36
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Ocera Therapeutics, Inc. 39
Clinical Trial Overview of Ocera Therapeutics, Inc. 39
Cato Research Ltd. 40
Clinical Trial Overview of Cato Research Ltd. 40
Botanic Century 41
Clinical Trial Overview of Botanic Century 41
Clinical Trial Overview of Top Institutes / Government 42
Japanese Foundation for Cancer Research 42
Clinical Trial Overview of Japanese Foundation for Cancer Research 42
Chiang Mai University 43
Clinical Trial Overview of Chiang Mai University 43
Nanjing PLA General Hospital 44
Clinical Trial Overview of Nanjing PLA General Hospital 44
Queen’s University 45
Clinical Trial Overview of Queen’s University 45
University Medicine Greifswald 46
Clinical Trial Overview of University Medicine Greifswald 46
Wakayama Medical University 47
Clinical Trial Overview of Wakayama Medical University 47
Academic Medical Center 48
Clinical Trial Overview of Academic Medical Center 48
Atrium Medical Center 49
Clinical Trial Overview of Atrium Medical Center 49
Azienda Ospedaliera Universitaria Policlinico catania 50
Clinical Trial Overview of Azienda Ospedaliera Universitaria Policlinico catania 50
Baqiyatallah Medical Sciences University 51
Clinical Trial Overview of Baqiyatallah Medical Sciences University 51
Five Key Clinical Profiles 52
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 80

List of Tables
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Ileus (Intestinal Obstruction) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Ileus (Intestinal Obstruction) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Ileus (Intestinal Obstruction) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Ileus (Intestinal Obstruction) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Ileus (Intestinal Obstruction) Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Ileus (Intestinal Obstruction) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tsumura & co., 2015* 31
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 33
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 34
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Norgine B.V., 2015* 35
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2015* 36
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 37
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 38
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocera Therapeutics, Inc., 2015* 39
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cato Research Ltd., 2015* 40
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Botanic Century, 2015* 41
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Foundation for Cancer Research, 2015* 42
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiang Mai University, 2015* 43
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing PLA General Hospital, 2015* 44
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2015* 45
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medicine Greifswald, 2015* 46
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Wakayama Medical University, 2015* 47
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 48
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Atrium Medical Center, 2015* 49
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria Policlinico catania, 2015* 50
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baqiyatallah Medical Sciences University, 2015* 51

List of Figures
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Ileus (Intestinal Obstruction) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Ileus (Intestinal Obstruction) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Ileus (Intestinal Obstruction) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Ileus (Intestinal Obstruction) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Ileus (Intestinal Obstruction) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Ileus (Intestinal Obstruction) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Ileus (Intestinal Obstruction) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Ileus (Intestinal Obstruction) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 79

【掲載企業】

Tsumura & co.
Valeant Pharmaceuticals International, Inc.
Merck & Co., Inc.
Norgine B.V.
Ipsen S.A.
GlaxoSmithKline plc
Pfizer Inc.
Ocera Therapeutics, Inc.
Cato Research Ltd.
Botanic Century

【レポートのキーワード】

イレウス(腸閉塞) (Ileus (Intestinal Obstruction))、治験、臨床試験、治験、治療薬

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ イレウス(腸閉塞) (Ileus (Intestinal Obstruction)):世界の治験レビュー(2015年上半期版)(Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆